Summary
Samenvatting Metabolism & Hormones 2 - Overige onderwerpen
Course
Metabolism & Hormones 2
SV van de lessen obesitas, dislipidemie, hypoglycemie bij non-diabetici
[Show more]
Preview 3 out of 26 pages
Uploaded on
January 10, 2025
Number of pages
26
Written in
2024/2025
Type
Summary
endocrinologie
endocrinology
stofwisseling
hormonen
hormones
metabolisme
metabolism
Institution
Universiteit Antwerpen (UA)
Education
Geneeskunde
Course
Metabolism & Hormones 2
All documents for this subject (7)
$8.61
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
METABOLISM & HORMONES 2
Overige onderwerpen
1
,Table of Contents
1 Obesitas...................................................................................................................................................... 4
Controle gewichtshomeostase..............................................................................................................................4
Wat is obesitas?....................................................................................................................................................4
Definitie............................................................................................................................................................4
BMI....................................................................................................................................................................4
Levensverwachting...........................................................................................................................................4
Epidemiologie...................................................................................................................................................4
Middelomtrek...................................................................................................................................................4
Effect op gezondheid........................................................................................................................................5
Oorzaken...............................................................................................................................................................5
Niet-wijzigbare oorzaken..................................................................................................................................5
Wijzigbare oorzaken.........................................................................................................................................7
Complicaties..........................................................................................................................................................7
Evaluatie...............................................................................................................................................................8
Behandeling..........................................................................................................................................................9
Conservatief......................................................................................................................................................9
Medicatie........................................................................................................................................................10
Chirurgie.........................................................................................................................................................10
2 Dislipidemie.............................................................................................................................................. 11
Classificatie van lipidenstoornissen....................................................................................................................12
LDL cholesterol...............................................................................................................................................12
Non-HDL cholesterol en triglyceriden............................................................................................................14
Lp(a)................................................................................................................................................................15
Behandeling van lipidenstoornissen...................................................................................................................16
Risicostratificatie en behandeldoelen............................................................................................................16
Non-farmacologische therapie.......................................................................................................................16
Farmacologische therapie..............................................................................................................................17
3 Hypoglycemie bij non-diabetici.................................................................................................................. 21
Definitie..............................................................................................................................................................21
Wanneer verder testen?.....................................................................................................................................21
Reactieve hypoglycemie.....................................................................................................................................21
Classificatie en differentiaaldiagnose.................................................................................................................22
Alcohol geïnduceerde hypoglycemie..................................................................................................................23
Hypglycemie bij kritische ziekte..........................................................................................................................23
Hypoglycemie bij hormonale deficiënties...........................................................................................................23
Extra-pancreatische neoplasmata geassocieerd met hypoglycemie.................................................................23
Hypoglycemie bij gezond ogende persoon.........................................................................................................23
Insulinoom..........................................................................................................................................................24
Differentiaaldiagnose hyperinsulinemische hypoglycemie.................................................................................25
2
, Conclusies...........................................................................................................................................................25
3